免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

LigaPASS™ 2.0 韧帶增強系統

K 號:K213659 · 2022-05-24

決定日期2022-05-24
產品代碼OWI
諮詢委員會或
決定相當於

器材摘要

LigaPASS™ 2.0 Ligament Augmentation System is the device name listed in this FDA 510(k) record. The listed applicant is Medicrea International SA. It received FDA 510(k) clearance on 2022-05-24 under 510(k) number K213659. The device is classified under product code OWI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the LigaPASS™ 2.0 Ligament Augmentation System?

LigaPASS™ 2.0 Ligament Augmentation System is a medical device that received FDA 510(k) clearance on 2022-05-24. The listed applicant is Medicrea International SA. The 510(k) number is K213659.

When did LigaPASS™ 2.0 Ligament Augmentation System receive FDA 510(k) clearance?

LigaPASS™ 2.0 Ligament Augmentation System received FDA 510(k) clearance on 2022-05-24, under 510(k) number K213659.

Who is the listed applicant for LigaPASS™ 2.0 Ligament Augmentation System?

The FDA 510(k) record lists Medicrea International SA as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LigaPASS™ 2.0 Ligament Augmentation System?

The FDA product code for LigaPASS™ 2.0 Ligament Augmentation System is OWI.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Medicrea International SA 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 21 項裝置 →

相關器械(代碼:OWI)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑